Worlds Leading Infectious Diseases Congress

Theme: Fighting Infectious Diseases with Novel and Innovative Therapeutic Techniques

Infectious Diseases 2016

Scientific program

Renowned Speakers

Glenn S Tillotson
Cempra Pharmaceuticals
USA

Thomas Licker
Infection Control Technologies
USA

Ashok Kapse
Mahavir Super Specialty Hospital
India

Paul Julius Caesar
University Medical Center Groningen
Netherlands

Amanuel Ateweberhan Woldemariam
Huazhong University of Science and Technology
China

Sion Jo
Chonbuk National University Hospital
Republic of Korea

Omotowo I Babatunde
University of Nigeria
Nigeria

Francis J. Castellino
University of Notre Dame
USA

EugÃ©nie Bergogne-BÃ©rÃ©zin
Centre Hospitalo-Universitaire Bichat- Claude Bernard University Diderot
France

Neeraj Kumar Tulara
Dr L H Hiranandani Hospital
India

Zharov Vladimir P
University of Arkansas for Medical Sciences
USA

Rachel Groppo
Sanofi Pasteur
USA

Stef Stienstra
Dutch Armed Forces / Royal Dutch Navy
Netherlands

Adriana MacÃªdo Dellâ€™ Aquila
Federal University of SÃ£o Paulo
Brazil

Jilei Zhang
Yangzhou University
China

Maria Luisa G Daroy,
St. Lukeâ€™s Medical Center
Philippines

Durgesh Sinha
Strayer University
USA

Maria Del Rosario DÃ¡valos Gamboa
University of San SimÃ³n
Bolivia

Joanna Zajkowska
Medical University of BiaÅ‚ystok
Poland

Lalit Garg
University of Malta
Malta

Ashraf Osman Abdellatif Mohamed
Cairo University
Egypt

Leena Bhattacharya Mithal
Northwestern University
USA

Infectious Diseases 2016

Track 01: Infectious Diseases

The diseases caused by germs and which may infect any part of the body are called infectious diseases. They can be spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.

Related Conferences

5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3^rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35^th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24^th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 02: Causes and Symptoms of Infectious Diseases

Infectious diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.

Related Conferences

Track 03: Global Trends in Emerging Infectious Diseases

An Infectious disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

Related Conferences

Track 04: Clinical Studies and Case Reports

Clinical studies helps in inventing new treatment methods which helps in providing effective treatment. Case reports on infectious diseases include research, biology, epidemiology and clinical aspects of all infection related diseases.

Related Conferences

Track 05: Microbial Pathogenesis and Virulence

Microbial pathogenesis is the study of the molecular mechanisms used by microorganisms to cause disease in humans and animals. By understanding how pathogens cause disease helps in the development of new therapeutic approaches. Virulence is the measure of the pathogenicity of an organism. The degree of virulence is related directly to the ability of the organism to cause infection despite host resistance mechanisms, it is affected by numerous variables such as the number of infecting bacteria, route of entry into the body, specific and nonspecific host defence mechanisms and virulence factors of the bacterium.

Related Conferences

Track 06: Immunology of Infections

Immunology of infections means the battle between pathogens and the host immune defences. Immunology is the branch of science concerned with the various aspects related to immune system, innate and acquired immunity. Immunology also deals with laboratory techniques involving the interaction of antigens with specific antibodies.

Related Conferences

Track 07: Mechanism of Resistance

Mechanism of resistance towards antimicrobials by microorganisms includes the following mechanisms of enzymatic destruction, enzymatic modification, altered target and decreased uptake. Mechanism of resistance is due to the inactivation or modification of antibiotics, an alteration in the target site of the antibiotic that reduces its binding capacity, the modification of metabolic pathways to circumvent the antibiotic effect and the reduced intracellular antibiotic accumulation by decreasing permeability and/ or increasing active efflux of the antibiotic.

Related Conferences

Track 08: Antimicrobial/ Antibiotic/ Antibacterial Resistance

Antimicrobial/ antibiotic/ antibacterial resistance is the ability of microorganisms to resist the effects of drugs that means diseases causing germs do not get killed and their growth is not stopped. Antibiotic resistant infections are of greater risk which cannot be avoided completely. Infections with resistant organisms are difficult to treat requiring costly and sometimes toxic alternatives.

Related Conferences

Track 09: Antimicrobial/ Antibiotic/ Antibacterial Stewardship

Antimicrobial/ antibiotic/ antibacterial stewardship promotes the appropriate use of antimicrobials which improves patient outcomes reduces microbial resistance and decreases the spread of infections caused by multidrug resistant organisms.

Related Conferences

Track 10: Epidemiology of Emerging and Re-Emerging Infectious Diseases

Epidemiology studies the patterns, causes and effects of health and disease conditions. It is the cornerstone of public health and informs policy decisions and evidence based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, data collection, statistical analysis of data, interpretation and dissemination. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.

Related Conferences

Track 11: Diagnosis of Infectious Diseases

Medical diagnosis is the process of determining which disease or condition explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include microscopy, culture and immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, western blot, precipitation tests and complement fixation tests) and nucleic acid/ non nucleic acid based identification methods. Sub types of diagnoses include clinical, laboratory, radiology, principal and admitting diagnosis. Advanced methods have been implemented to diagnose the infection in any part of the body. Examples include biomarkers/ elisa test/ chest x ray/ skin biopsy/ tympanometry and tympanocentesis.

Related Conferences

Track 12: Treatment for Infectious Diseases

Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Yeast infections can be primarily treated by sterilisation methods. Parasitic infections can be treated by antiparasitic drugs. Diseases such as cancer can be treated by chemotherapy. Recent techniques have proved that there is no disease that cannot be treated.

Related Conferences

Track 13: Infectious Diseases Prevention, Control and Cure

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the application of heat. Disinfection is the process of killing harmful microorganisms. Some infectious diseases can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks. Infections can be cured by various antimicrobials.

Related Conferences

Track 14: Infectious Diseases Vaccines

Infectious diseases vaccines are the vaccines which prevent the infectious diseases and infectious diseases like diphtheria, haemophilus influenzae serotype b infection, hepatitis b, measles, meningitis, mumps, pertussis, poliomyelitis, rubella, tetanus, tuberculosis and yellow fever are preventable through vaccines.

Related Conferences

Track 15: Sexually Transmitted Diseases/ Sexually Transmitted Infections

Sexually transmitted diseases/ sexually transmitted infections are the infections which are transmitted through sexual contact with an infected individual and also transmitted during vaginal or other types of sexual intercourse including oral and anal sex.

Related Conferences

Track 16: Pediatric Infectious Diseases/ Childhood Infectious Diseases

Pediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of different age groups. Pediatric infectious diseases specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults.

Related Conferences

Track 17: Neuro Infectious Diseases

Neuro infectious diseases are the infectious diseases which are observed in the nervous system. Viral and immune mediated disorders of the nervous system are among the most challenging neurological disorders. The most common neuro immune disorder is multiple sclerosis and hiv is the most common viral infection of the nervous system.

Related Conferences

Track 18: Noscomial Infections/ Hospital Acquired Infections/ Health Care Associated Infections

Nosocomial infections/ hospital acquired infections/ health care associated infections are the infections that are contracted from the environment or staff of a healthcare facility and they spread in the hospital environment, nursing home environment, rehabilitation facility and clinic or other clinical settings.

Related Conferences

Track 19: Blood Stream Infections/ Bacteraemia/ Septicaemia/ Blood poisoning

Blood stream infections/ bacteraemia/ septicaemia/ blood poisoning occurs when a bacterial infection elsewhere in the body such as in the lungs or skin which enters the blood stream. This is dangerous because the bacteria and their toxins can be carried through the blood stream to the entire body.

Related Conferences

Track 20: Urinary Tract Infections

Urinary tract infections are the infections which are observed in any part of the urinary system (kidneys, ureters, bladder and urethra). Mostly infections are observed in the lower urinary tract (bladder and urethra). Women are at greater risk than men.

Related Conferences

Track 21: Surgical Site Infections

Surgical site infections are the infections which may occur within 30 days after the operation and are observed in the parts of skin and subcutaneous tissue of the incision.

Related Conferences

Track 22: Ebola and Current Research

Ebola virus disease is caused by virus transmitted through body fluids and through air. It occurs rarely but it is very deadly which results in death and outbreak. Ebola virus disease symptoms are very severe which appears in 2-3 days. Ebola primary symptoms include fever, sore throat, muscular pain and headaches then followed by vomiting, diarrhea, rash, decreased function of the liver and kidneys then loss of blood internally and externally finally leading to low blood pressure and fluid loss resulting in death.

Related Conferences

Track 23: Tuberculosis

Tuberculosis is a bacterial infection caused by a bacterium called mycobacterium tuberculosis which spread through the lymph nodes and blood stream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine and brain.

Related Conferences

Track 24: Hepatitis

Hepatitis is caused by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis may occur with limited or no symptoms but often leads to jaundice, poor appetite and malaise. Hepatitis is acute when it lasts less than six months and chronic when it persists longer.

Related Conferences

Track 25: Malaria

Malaria is a mosquito borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single celled microorganisms) belonging to the plasmodium type. Malaria symptoms typically include fever, fatigue, vomiting and headaches which can be observed in 10-15 after being bitten by mosquito. In severe cases it can cause yellow skin, seizures, comaor and even death.

Related Conferences

Track 26: Microbial Forensics and Molecular Basis of Bacteria

Microbial forensics and molecular basis of bacteria is defined as a scientific discipline which is used to analyse microorganism/ toxin release.

Related Conferences

Track 27: Animal Infectious Diseases/ Zoonosis

Animal infectious diseases/ zoonosis are important threat to human health since the emergence of human diseases is dominated by zoonotic pathogens. Infectious diseases affect livestock and also wild animals focusing on characterizing the conditions for the pathogen spread and maintenance in the host population.

Related Conferences

Track 28: Plant Disease Modelling and Parameter Estimation

Plant pathology is the study of diseases in plants caused by pathogens and environmental conditions. Organisms that cause infectious diseases include fungi, oomycetes, bacteria, viruses, viroids, virus like organisms, phytoplasmas, protozoa, nematodes and parasitic plants. Plant pathology also involves the study of pathogen identification, disease etiology, disease cycles, economic impact, plant disease epidemiology, plant disease resistance, how plant diseases affect humans and animals, pathosystem genetics and management of plant diseases.

Related Conferences

Track 29: Global Market on Infectious Diseases

Global market report of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Related Conferences

Track 30: Entrepreneurs Investment Meet

Entrepreneurs from infectious diseases field can exhibit their products and can give presentations on their products which should be helpful in research work, business development and marketing.

Related Conferences

ConferenceSeries Ltd Conferences invites all the participants from all over the world to attend “2^nd World Congress on Infectious Diseases” during August 24-26, 2016 in Philadelphia, Pennsylvania, USA which includes prompt keynote presentations, special sessions, workshops, symposiums, oral talks, poster presentations and exhibitions.

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of microbiology especially clinical and diagnostic microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases like Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

Who should attend?

Microbiologists
Bacteriologists
Virologists
Parasitologists
Mycologists
Pathologists
Pharmacists
Epidemiologists
Health Care Professionals
Infectious Diseases Specialists
Infection Prevention and Infection Control Specialists

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targeted Audience

Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Medical Colleges
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists
Training Institutes
Software Developing Companies
Data Management Companies

For Scientific Sessions please go through the link: http://infection.omicsgroup.com/call-for-abstracts.php

For Abstract Submission please go through the link: http://infection.omicsgroup.com/abstract-submission.php

Infectious Diseases Therapeutic Market

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.

Infectious Diseases Diagnostics Market

Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.

Worldwide deaths due to Infectious Diseases

Current Outbreak

The deadliest Ebola outbreak in recorded history is happening right now. The outbreak is unprecedented both in the number of cases and in its geographic scope. And so far, it doesn't look like it's slowing down.

The outbreak has now hit three countries: Guinea, Sierra Leone, and Liberia. And the virus — which starts off with flu-like symptoms and often ends with horrific hemorrhaging — has infected about 600 people and killed an estimated 367 since this winter, according to the numbers on June 26 from the World Health Organization.

Members associated with Infectious Diseases

Centre for Infectious Diseases and Policy includes 218 members
Global Public Health is having 106913 members
Members Pediatric Infectious Disease and Immunology has 3291 members
European Society of Clinical Microbiology and Infectious Diseases has 3438 members
Infectious Diseases Society has 707 members

Worldwide Data

Worldwide members of Infectious are 3,683 members
European Congress in Clinical Microbiology and Infectious Diseases is having 1,369 members
National Foundation for Infectious Diseases has 365 members
UNC Institute for Global Health & Infectious Diseases has237 members
Cirion; bridging the gap in infectious diseases between science and society has55 members
HIV/AIDS & Infectious Diseases has 85 members
M.S. in Public Health Microbiology & Emerging Infectious Diseases has 44 members
Infectious Diseases and Public Health (IDPH) Research Group has 45 members
EUPHA Section Infectious diseases control has 38 members
Center for Structural Genomics of Infectious Diseases (CSGID) has30 members
LSHTM_Control of Infectious Diseases has 19 members

Societies and Associations related to Infectious Diseases

Healthcare Infection Society
European Society for Pediatric Infectious Diseases
European Society of Clinical Microbiology and Infectious Diseases
Infection Prevention Society
British Society for Immunology
British Infection Association
British Infection Association
European Society for pediatric Infectious diseases
Health care Infection Society
Worldwide societies for infectious diseases is about 150

Universities related to Infectious Diseases

University of Cambridge
Kings College of London
London School of Hygiene and Tropical Medicine
Imperial College London
UCL Institute of Epidemiology and Health care
University of Sheffeild
Pediatric Infectious Diseases Society
Columbia University
University of Maryland
Swedish Institute for Infectious Disease Control
Uppsala University
University of Gothenburg
University of Otago
Oslo University
University of Pittsburgh
Emory Health Sciences
Queensland University of Technology
University of Liverpool
University of Colorado Denver
Infectious Diseases Society of America
Medical College of Georgia at Georgia Regents University

Market Analysis of Companies

Funding towards Infectious Diseases

NIH funding for Infectious Diseases

References

http://www.mayoclinic.org/diseases-conditions/infectious-diseases/basics/definition/con- 20033534
http://ije.oxfordjournals.org/content/32/5/684.full
http://www.jblearning.com/samples/0763728799/28799_CH01_001_022.pdf
https://www.research.olemiss.edu/UMQuest/2007/Winter/ThePowerOfPartnerships.html
http://ije.oxfordjournals.org/content/32/5/684.full
http://www.ncbi.nlm.nih.gov/books/NBK56579/
http://www.nhshistory.net/voluntary_hospitals.html
http://www.vox.com/2014/6/26/5839394/the-deadliest-ebola-outbreak-in-history-is-happening-right-now
http://en.wikipedia.org/wiki/List_of_hospitals_in_England
http://www.healthcare.bayer.com/scripts/pages/en/company/products/index.php
http://kff.org/global-health-policy/fact-sheet/the-u-s-government-and-global-tuberculosis/
http://report.nih.gov/categorical_spending.aspx
Murray JM, Law MG, Gao Z, Kaldor JM. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol 2003;32: 708–14.
Law MG, Dore GJ, Bath N et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003;32:717–24.
Lederberg J, Shope RE (eds). Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press, 1992.
Watts S. Epidemics and History: Disease, Power and Imperialism.New Haven, Conn: Yale University Press; 1997
Lee HSJ, ed. Dates in Infectious Diseases. Boca Raton, Fla: The Parthenon Publishing Group; 2000.
Fears JR. The plague under Marcus Aurelius and the decline and fall of the Roman Empire. Infect Dis Clin North Am. 2004;18:65–77.
Antonine plague. Wikipedia Web page. Available at: http://en.wikipedia.org/wiki/Antonine_Plague. Accessed Feb 22, 2006.
Porter R, ed. Cambridge Illustrated History of Medicine. New York, NY: Cambridge University Press; 1996.
Rosen G. A History of Public Health. Baltimore, Md: Johns Hopkins University Press; 1993.
McNeill WH. Plagues and Peoples.New York, NY: Doubleday; 1977.
Hirst LF. The Conquest of Plague. London, England: Oxford University Press; 1953.
Duncan SR, Scott S, Duncan CJ. Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation. J Med Genet. 2005; 42:205–208.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 24-25, 2016
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2	Day 3
Poster Opportunity Closed	Click Here to View

Media Partners

Testimonials

I got the impression that the delegates were happy with the scientific program of this Infectious Diseases 2015. It was great to have such an international audience. I was happy with the positive response of all the conference audience. I am willing to contribute to for Infectious Diseases 2016, Philadelphia, USA, August 24-26, 2016.
Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands

I am very happy and grateful for your help. We appreciate your speedy response and your support. Many thanks and sincere gratitude I want to express Jennifer Ojeda for your efficiency and responsiveness as well as to thank all the members of the organizing committee of Infectious Diseases 2015. Thank you for your good deeds.
Nargiz Sultanova, Azerbaijan National Academy of Sciences, Azerbaijan

This will be a great opportunity for me to prove myself as my carrier is just started. I have no words to express my gratitude towards Conference Series LLC conferences, really a great experience to communicate with u all, always ready to support, really thank you once again.
Himani B Pandya, SBKS Medical College, India

Thanks greatly for your respect and support to us, actually we are honour to participate in Infectious Diseases 2015. Thanks greatly for you that make our message go to the world through this great conference.
Heba Ezzat Hashem, Ain Shams University, Egypt

The pleasure it is for mine to participate in such a great event. Thanks a lot. Hope to see you in next year conference Infectious Diseases 2016.
Aouf Abdel Hakim, University of Sciences and Technology Houari Boumediene, Algeria

Thank you very much for your excellent organization of Infectious Diseases 2015. It was a great success.
Luke Hunt, Liverpool School of Tropical Medicine, UK

Thank you so much for the opportunity of learning with all the colleagues I met there.
Ana MarÃa Arnaiz GarcÃa, University Hospital MarquÃ©s De Valdecilla, Spain

The congress Infectious Diseases 2015 was fantastic event for scientific community.
Sandra Milena ChingatÃ©, Universidad Nacional De Colombia, Colombia

Thank you very much for your cooperation for Infectious Diseases 2015.
Maria Del Rosario DÃ¡valos Gamboa, University of San SimÃ³n, Bolivia

Thank you so much for your great effort for Infectious Diseases 2015.
Shereen Ahmed El Masry, Ain Shams University, Egypt

For me Infectious Diseases 2015 was a great event.
Anna Moniuszko Malinowska, Medical University of BiaÅ‚ystok, Poland

2^nd World Congress on Infectious Diseases August 24-25, 2016 Pennsylvania, Philadelphia, USA

Recommended Global Infectious Diseases Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Infectious Diseases 2016

Track 30: Entrepreneurs Investment Meet

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Useful Links

Special Issues

Testimonials